David A. Siegel Hepion Pharmaceuticals, Inc. Put Options Transaction History
Two Sigma Advisers, LP
- $41.3 Billion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
About Hepion Pharmaceuticals, Inc.
- Ticker HEPA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,229,600
- Market Cap $49.5M
- Description
- Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing Rencofilstat, a cyclophilin inhibitor that has completed Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver...